{"id":13989,"date":"2018-07-16T17:24:44","date_gmt":"2018-07-16T11:54:44","guid":{"rendered":"https:\/\/blog.fundsindia.com\/blog\/?p=13858"},"modified":"2018-07-16T17:24:44","modified_gmt":"2018-07-16T11:54:44","slug":"sun-pharmaceutical-industries-ltd","status":"publish","type":"post","link":"https:\/\/fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989","title":{"rendered":"Sun Pharmaceutical Industries Ltd"},"content":{"rendered":"<p>Sun Pharma is India\u2019s top drug maker and world&#8217;s fifth largest specialty generic pharmaceutical company by revenue with 41 manufacturing facilities spread across 6 continents.<\/p>\n<p><strong>Outlook and Valuation:<\/strong> Clearance of Halol facility, ramp up of generics and specialty business driven by increased investments augurs well for the company as it improves the launch visibility. Sun Pharma has been investing heavily to build a pipeline of specialty products for the US market. Moreover, expectation of further market share gains in Odomzo and BromSite (launched in FY17), recovery in India business, improved launch visibility and key specialty &amp; generic launches will support growth. Hence, we recommend \u2018BUY\u2019 rating with a target price of Rs 623 based on 24x FY20E EPS.<\/p>\n<p><a href=\"https:\/\/blog.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/Research-Report-Sun-Pharma.pdf\">Research-Report &#8211; Sun Pharma<\/a><\/p>\n<p><em>Investments in equity shares, debentures, etc., are not obligations of, or guaranteed by Wealth India Financial Services Pvt. Ltd., and are subject to investment risks.\u00a0<\/em><a href=\"http:\/\/pages.fundsindia.com\/pages\/disclaimer-equities\/\"><em>Click here<\/em><\/a><em>\u00a0to read our full disclaimer.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sun Pharma is India\u2019s top drug maker and world&#8217;s fifth largest specialty generic pharmaceutical company by revenue with 41 manufacturing facilities spread across 6 continents. Outlook and Valuation: Clearance of Halol facility, ramp up of generics and specialty business driven by increased investments augurs well for the company as it improves the launch visibility. Sun [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[59],"tags":[564],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v17.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sun Pharmaceutical Industries Ltd<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sun Pharmaceutical Industries Ltd\" \/>\n<meta property=\"og:description\" content=\"Sun Pharma is India\u2019s top drug maker and world&#8217;s fifth largest specialty generic pharmaceutical company by revenue with 41 manufacturing facilities spread across 6 continents. Outlook and Valuation: Clearance of Halol facility, ramp up of generics and specialty business driven by increased investments augurs well for the company as it improves the launch visibility. Sun [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989\" \/>\n<meta property=\"og:site_name\" content=\"Insights\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fundsindia\" \/>\n<meta property=\"article:published_time\" content=\"2018-07-16T11:54:44+00:00\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Equities Desk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\",\"name\":\"Wealth India Financial Services\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/fundsindia\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg\",\"contentUrl\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg\",\"width\":189,\"height\":200,\"caption\":\"Wealth India Financial Services\"},\"image\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#website\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/\",\"name\":\"Insights\",\"description\":\"Official blog of FundsIndia.com\",\"publisher\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fundsindia.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#webpage\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989\",\"name\":\"Sun Pharmaceutical Industries Ltd\",\"isPartOf\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#website\"},\"datePublished\":\"2018-07-16T11:54:44+00:00\",\"dateModified\":\"2018-07-16T11:54:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fundsindia.com\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sun Pharmaceutical Industries Ltd\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#webpage\"},\"author\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656\"},\"headline\":\"Sun Pharmaceutical Industries Ltd\",\"datePublished\":\"2018-07-16T11:54:44+00:00\",\"dateModified\":\"2018-07-16T11:54:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#webpage\"},\"wordCount\":157,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\"},\"keywords\":[\"Sun Pharmaceutical Industries Ltd\"],\"articleSection\":[\"Equity Research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656\",\"name\":\"Equities Desk\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g\",\"caption\":\"Equities Desk\"},\"sameAs\":[\"http:\/\/www.fundsindia.com\"],\"url\":\"https:\/\/fundsindia.com\/blog\/author\/equities-desk\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sun Pharmaceutical Industries Ltd","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989","og_locale":"en_US","og_type":"article","og_title":"Sun Pharmaceutical Industries Ltd","og_description":"Sun Pharma is India\u2019s top drug maker and world&#8217;s fifth largest specialty generic pharmaceutical company by revenue with 41 manufacturing facilities spread across 6 continents. Outlook and Valuation: Clearance of Halol facility, ramp up of generics and specialty business driven by increased investments augurs well for the company as it improves the launch visibility. Sun [&hellip;]","og_url":"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989","og_site_name":"Insights","article_publisher":"https:\/\/www.facebook.com\/fundsindia","article_published_time":"2018-07-16T11:54:44+00:00","twitter_misc":{"Written by":"Equities Desk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/www.fundsindia.com\/blog\/#organization","name":"Wealth India Financial Services","url":"https:\/\/www.fundsindia.com\/blog\/","sameAs":["https:\/\/www.facebook.com\/fundsindia"],"logo":{"@type":"ImageObject","@id":"https:\/\/www.fundsindia.com\/blog\/#logo","inLanguage":"en-US","url":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg","contentUrl":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg","width":189,"height":200,"caption":"Wealth India Financial Services"},"image":{"@id":"https:\/\/www.fundsindia.com\/blog\/#logo"}},{"@type":"WebSite","@id":"https:\/\/www.fundsindia.com\/blog\/#website","url":"https:\/\/www.fundsindia.com\/blog\/","name":"Insights","description":"Official blog of FundsIndia.com","publisher":{"@id":"https:\/\/www.fundsindia.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fundsindia.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#webpage","url":"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989","name":"Sun Pharmaceutical Industries Ltd","isPartOf":{"@id":"https:\/\/www.fundsindia.com\/blog\/#website"},"datePublished":"2018-07-16T11:54:44+00:00","dateModified":"2018-07-16T11:54:44+00:00","breadcrumb":{"@id":"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fundsindia.com\/blog"},{"@type":"ListItem","position":2,"name":"Sun Pharmaceutical Industries Ltd"}]},{"@type":"Article","@id":"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#article","isPartOf":{"@id":"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#webpage"},"author":{"@id":"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656"},"headline":"Sun Pharmaceutical Industries Ltd","datePublished":"2018-07-16T11:54:44+00:00","dateModified":"2018-07-16T11:54:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#webpage"},"wordCount":157,"commentCount":0,"publisher":{"@id":"https:\/\/www.fundsindia.com\/blog\/#organization"},"keywords":["Sun Pharmaceutical Industries Ltd"],"articleSection":["Equity Research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fundsindia.com\/blog\/equities\/sun-pharmaceutical-industries-ltd\/13989#respond"]}]},{"@type":"Person","@id":"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656","name":"Equities Desk","image":{"@type":"ImageObject","@id":"https:\/\/www.fundsindia.com\/blog\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g","caption":"Equities Desk"},"sameAs":["http:\/\/www.fundsindia.com"],"url":"https:\/\/fundsindia.com\/blog\/author\/equities-desk"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/13989"}],"collection":[{"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/comments?post=13989"}],"version-history":[{"count":0,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/13989\/revisions"}],"wp:attachment":[{"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/media?parent=13989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/categories?post=13989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/tags?post=13989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}